Delapav en es it fr

Delapav Brand names, Delapav Analogs

Delapav Brand Names Mixture

  • No information avaliable

Delapav Chemical_Formula


Delapav RX_link

Delapav fda sheet

Delapav msds (material safety sheet)

Delapav Synthesis Reference

No information avaliable

Delapav Molecular Weight

339.385 g/mol

Delapav Melting Point

No information avaliable

Delapav H2O Solubility

No information avaliable

Delapav State


Delapav LogP


Delapav Dosage Forms


Delapav Indication

For the treatment of impotence

Delapav Pharmacology

Papaverine is a nonxanthine phosphodiesterase inhibitor for the relief of cerebral and peripheral ischemia associated with arterial spasm and myocardial ischemia complicated by arrhythmias. The main actions of Papaverine are exerted on cardiac and smooth muscle. Like qathidine, Papaverine acts directly on the heart muscle to depress conduction and prolong the refractory period. Papaverine relaxes various smooth muscles. This relaxation may be prominent if spasm exists. The muscle cell is not paralyzed by Papaverine and still responds to drugs and other stimuli causing contraction. The antispasmodic effect is a direct one, and unrelated to muscle innervation. Papaverine is practically devoid of effects on the central nervous system. Papaverine relaxes the smooth musculature of the larger blood vessels, especially coronary, systemic peripheral, and pulmonary arteries.

Delapav Absorption

No information avaliable

Delapav side effects and Toxicity

No information avaliable

Delapav Patient Information

No information avaliable

Delapav Organisms Affected

Humans and other mammals